Abstract
A 56-yr-old woman developed severe Cushing's syndrome and recurrent malignant melanoma three years after the removal of the primary lesion. She had elevated plasma cortisol levels which showed no normal diurnal rhythm. Neither these nor her elevated urinary steroid excretion were suppressed by administration of high doses of dexamethasone. She had markedly elevated plasma immunoreactive ACTH levels. Bioactive and immunoreactive ACTH was present in an extract of the metastic tumor tissue. This is the first documented case of ectopic ACTH syndrome caused by malignant melanoma. The patient, who was moribund from the effects of severe hypercortisolism, was cured of her Cushing's syndrome by the combined administration of aminoglutethimide, metyrapone, and o,p'DDD. She was dramatically improved clinically, despite steady progression of tumor growth. It appears that the use of o,p'DDD, especially in combination with inhibitors of adrenal steroid biosynthesis, is an effective means for correcting hypercortisolis...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The Journal of clinical endocrinology and metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.